Medstar Health Research Institute
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Medstar Health Research Institute sits in the top decile of US sponsors by registered trial count (#223 of 15,742 sponsors by registered trial count).
Medstar Health Research Institute: 115 sponsored US clinical trials, 23 recruiting.
Medstar Health Research Institute sponsors 115 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 65 completed. 16 of these trials are in Phase 3-4 (later-stage) and 18 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Neurogenic Bladder, with 5 trials.
Top-decile sponsor footprint
Medstar Health Research Institute ranks in the top decile of sponsors by registered trial count (#223 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
65 of 83 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
115 total, page 2 of 3
Characterization of Dyschromic Hypertrophic Scar
NCT04619589
Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device
NCT03925324
Personalized Voice Activated Wellness Assistants for Patients With Heart Failure
NCT03707275
Virtual Reality for Pain Management in Advanced Heart Failure
NCT04572425
An Outcome Evaluation of the Project CHANGE-MS Violence Intervention Program
NCT04567381
Non-opioid Based Pain Control After Thyroidectomy
NCT03988075
Identification of the Pre-exposure Prophylaxis (PrEP) Cascade for Women.
NCT03705663
A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting
NCT04516148
Study to Determine Therapeutic Massage Dosing to Improve Quality of Life in Hospitalized Patients Receiving Palliative Care
NCT04916223
Use of Negative Pressure Wound Therapy in Morbidly Obese Women After Cesarean Delivery
NCT03269968
Gabapentin for Pain Management During Dilation and Evacuation
NCT03635905
Sexual Function Trial of Overactive Bladder: Medication Versus PTNS
NCT03500146
99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients
NCT03065218
Registry Experience at the Washington Hospital Center With Drug Eluting Stents - Synergy
NCT02823730
Diabetes to Go: Inpatient Education Implementation
NCT03623607
A Randomized Controlled Trial of Three Antibiotic Regimens for First Trimester Abortions
NCT02756403
Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
NCT02628899
Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB
NCT02748317
Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB
NCT02748356
Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus
NCT02573883
Healing Statements and Their Effect on Post Operative Pain
NCT02502357
The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Venous Access-Site Closure
NCT02438475
PTNS vs Botox of Refractory OAB
NCT04451382
Comparing Misoprostol Alone to Dilapan With Misoprostol and Comparing Buccal to Vaginal Misoprostol
NCT02363556
MedStar Health Type 2 Diabetes Pathway to Control
NCT02925312
REWARDS Premier Taxus-Liberte vs Xience V
NCT02256527
Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH)
NCT02213757
Effect of a Risk Calculator on Patient Satisfaction With the Decision for Midurethral Sling During Prolapse Surgery
NCT02111642
Cardiac Safety Study in Patients With HER2 + Breast Cancer
NCT01904903
Nerve Burial for Preventing Neuralgia After Total Knee Arthroplasty
NCT02885467
Renal Denervation in Patients With Uncontrolled Blood Pressure
NCT01968785
The ACS Ethnicity Platelet Function Study
NCT01829659
The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage
NCT01916928
Chronology of Occult and Gross Coagulopathy in Burn Patients
NCT01638481
The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 Diabetes
NCT02269098
Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy
NCT03115515
Viability Imaging in Volumetric Angiography (VIVA 1)
NCT01408134
Transcatheter Aortic Valve Intervention-Live Transmission
NCT01353287
Assessment of the Number of Umbilical Cord Vessels at the Time of Nuchal Translucency Screening
NCT01367132
Platelet Function Monitoring in Patients With Acute Myocardial Infarction
NCT01353261
The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of Clopidogrel
NCT01365221
Dilators for Dyspareunia Prevention
NCT01299363
Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma
NCT01206296
Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V
NCT01134159
Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?
NCT01101750
Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine
NCT01152229
Drug Eluting Stent Registry of Thrombosis
NCT00812552
Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer
NCT00810017
Comparison of Iodine-124 (I-124) and Iodine-131 (I-131) Radiopharmacokinetics in Patients Prepared With Recombinant Human TSH Injection (rhTSH)
NCT00926978
Comparison of I-124 and I-131 Radiopharmacokinetics in DTC Patients With Thyroid Hormone Withdrawal
NCT02947399
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 15 |
| Phase 3 | 4 |
| Phase 4 | 12 |
Therapeutic Areas
What is open in the Medstar Health Research Institute pipeline
23 recruiting of 115 indexed (20% open); 65 completed (57%).
Phase mix: 16 late (III/IV) vs 18 early (I/II) (balanced across stages).
Top condition: Neurogenic Bladder (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medstar Health Research Institute: open-pipeline peers nationwide
Peers matched on 115 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Medstar Health Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 115 trials (± recruiting share)
- Medtronic Cardiac Rhythm and Heart Failure · 115 trials · 2% recruiting
- Zimmer Biomet · 115 trials · 10% recruiting
- Rockefeller University · 117 trials · 4% recruiting
- State University of New York - Upstate Medical University · 113 trials · 7% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
Related
What to do with this Medstar Health Research Institute page
115 registered trials is a research-attention snapshot, not an endorsement of Medstar Health Research Institute or any single study.
- 23 of Medstar Health Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Neurogenic Bladder is the condition Medstar Health Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Neurogenic Bladder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Medstar Health Research Institute pipeline card: 115 registered trials from official public datasets.Report a data error.